Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Setmelanotide, a selective agonist of the MC4R, is approved by the FDA and EMA for the treatment of obesity and control of hunger in Bardet-Biedl Syndrome or biallelic pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency in affected children above age 2 years-old [103]
The Deciding Factor If you take away one sentence from this article, take this one
The standard maintenance dose is 1 mg once a week
Frequently Asked Questions Is 5-Amino-1MQ better taken orally or by injection
US$ 22.04
US$ 20.06
US$ 20.19
